Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2025-12-17 @ 12:03 PM
Study NCT ID:
NCT06454266
Status:
None
Last Update Posted:
2024-07-30 00:00:00
First Post:
2024-05-05 00:00:00
Brief Title:
First-line Treatment of PCNSL With the Combination of Orelabrutinib, Rituximab, and Methotrexate (ORM Regimen)
Sponsor:
Ningbo No 1 Hospital
Organization:
Ningbo No. 1 Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-25
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-05 00:00:00
First Submit QC Date:
June 8 2024
Study First Post Date:
2024-06-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-28 00:00:00
Last Update Post Date:
2024-07-30 00:00:00
Last Update Post Date Type:
ACTUAL